DIRECT BIOLOGICS LLC

In News

Rett Syndrome Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Globe and Mail

The Globe and Mail - Dec 15, 2025

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

FibroBiologics (Nasdaq: FBLG) prices $1.7M direct sale and related $1.7M warrants - Stock Titan

Stock Titan - Dec 15, 2025

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - Newswire.com

Newswire.com - Jan 12, 2021

Direct Biologics Appoints Dr. Amy Lightner as Chief Medical Officer - citybiz

citybiz - Feb 15, 2023

Exosomes Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

The Globe and Mail - May 19, 2025

Bankruptcy Law And Charging Order Law Collide Again In Pettine - Forbes

Forbes - Nov 23, 2023

Bioclinica Partners with Direct Biologics to Provide Interactive Response Technology (IRT) Solution for COVID-19 Study - PR Newswire

PR Newswire - Sep 09, 2020

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo™ - BioInformant

BioInformant - Aug 02, 2020

Biotech targeting chronic diseases raises $1.7M in stock sale - Stock Titan

Stock Titan - Dec 16, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment